Summary
Treatment of Madin-Darby canine kidney (MDCK) cells with ≥ 10 ng/ml of recombinant murine tumor necrosis factor-α (rm TNF-α) prior to inoculation with influenza A/PR/8/34, (H1N1), resulted in decreased production of infectious virus as determined by plaque assay, inhibition of viral protein synthesis and a reduction in cytopathic effect. The inhibition of viral replication in vitro suggests a role for TNF-α in the host's defense against influenza A virus infections.
References
Dinarello CA, Cannon JG, Wolff SM, Bernheim HA, Beutler B, Cerami A, Figari IS, Palladino MA Jr, O'Connor JV (1986) Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med 163: 1433–1450
Ennis RA, Rook AH, Hua QY (1981) HLA-restricted virus-specific cytotoxic T-lymphocyte responses to live and inactivated influenza vaccines. Lancet ii: 887–891
Feduchi E, Carrasco L (1991) Mechanism of inhibition of HSV-1 replication by tumor necrosis factor and interferon-γ. Virology 180: 822–825
Hennet T, Ziltner HJ, Frei K, Peterhans E (1992) A kinetic study of immune mediators in the lungs of mice infected with influenza A virus. J Immunol 149: 932–939
Ito M, O'Malley JA (1987) Antiviral effects of recombinant human tumor necrosis factor. Lymphokine Res 6: 309–318
Jones PD, Ada GL (1986) Influenza virus-specific antibody-secreting cells in the murine lung during primary influenza virus infection. J Virol 60: 614–619
Koff WC, Fann AV (1986) Human tumor necrosis factor-alpha kills herpesvirus-infected but not normal cells. Lymphokine Res 5: 215–221
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680–685
Locardi C, Petrini C, Boccoli G, Testa U, Dieffenbach C, Butto S, Belardelli F (1990) Increased human immunodeficiency virus (HIV) expression in chronically infected U937 cells upon in vitro differentiation by hydroxyvitamin D3: roles of interferon and tumor necrosis factor in regulation of HIV production. J Virol 64: 5874–5882
Mak NK, Leung KN, Ada GL (1982) The generation of ‘cytotoxic’ macrophages in mice during infection with influenza A or Sendai virus. Scand J Immunol 15: 553–561
Matsuyama T, Hamamoto Y, Okamoto T, Shimotohno K, Kobayashi N, Yamamoto N (1988) Tumour necrosis factor and HIV: a note of caution. Lancet: 1364
Mellors JW, Griffith BP, Ortiz MA, Landry ML, Ryan JL (1991) Tumor necrosis factor-α/cachectin enhances human immunodeficiency virus type 1 replication in primary macrophages. J Infect Dis 163: 78–82
Mestan J, Digel W, Mittnacht S, Hillen H, Blohm D, Moller A, Jacobsen H, Kirchner H (1986) Antiviral effects of recombinant tumour necrosis factor in vitro. Nature 323: 816–818
Mestan J, Brockhaus M, Kirchner H, Jacobsen H (1988) Antiviral activity of tumour necrosis factor. Synergism with interferons and induction of oligo-2′,5′-adenylate synthetase. J Gen Virol 69: 3113–3120
Murphy BR, Chalhub EG, Nusinoff SR, Kasel J, Chanock RM (1973) Temperature-sensitive mutants of influenza virus. III. Further characterization of the ts-1[E] influenza A recombinant (H3N2) virus in man. J Infect Dis 128: 479–487
Nain M, Hinder F, Gong J-H, Schmidt A, Bender A, Sprenger H, Gemsa D (1990) Tumor necrosis factor-α production of influenza A virus-infected macrophages and potentiating effect of lipopolysaccharides. J Immunol 145: 1921–1928
Notka M, Matzke D, Jennings M, Schlick E, Nadler PI, Pollard R (1991) In vivo administration of tumor necrosis factor-α is associated with antiviral activity in human peripheral mononuclear cells. Proc Soc Exp Biol Med 197: 144–149
Rossol-Voth R, Rossol S, Schutt KH, Corridori S, de Cian W, Falke D (1991) In vivo protective effect of tumour necrosis factor-α against experimental infection with herpes simplex virus type 1. J Gen Virol 72: 143–147
Toms GL, Davies JA, Woodward CG, Sweet C, Smith H (1977) The relationship of pyrexia and nasal inflammatory response to virus levels in nasal washings of ferrets infected with influenza viruses of differing virulence. Br J Exp Pathol 58: 444–458
Vacheron F, Rudent A, Perin S, Labarre C, Quero AM, Guenounou M (1990) Production of interleukin 1 and tumour necrosis factor activities in bronchoalveolar washings following infection of mice with influenza virus. J Gen Virol 71: 477–479
Van Damme J, De Ley M, Van Snick J, Dinarello CA, Billiau A (1987) The role of interferon-β1 and the 26-kDa protein (interferon-β2) as mediators of the antiviral effect of interleukin 1 and tumor necrosis factor. J Immunol 139: 1867–1872
Wong GHW, Goeddel DV (1986) Tumour necrosis factors α and β inhibit virus replication and synergize with interferons. Nature 323: 819–822
Wong GHW, Krowka JF, Stites DP, Goeddel DV (1988) In vitro anti-human immunodeficiency virus activities of tumor necrosis factor-α and interferon-γ. J Immunol 140: 120–124
Wyde PR, Peavy DL, Cate TR (1978) Morphological and cytochemical characterization of cells infiltrating mouse lungs after influenza infection. Infect Immun 21: 140–146
Yap KL, Ada GL, McKenzie IFC (1978) Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature 273–238
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Van Campen, H. Influenza A virus replication is inhibited by tumor necrosis factor-α in vitro. Archives of Virology 136, 439–446 (1994). https://doi.org/10.1007/BF01321073
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01321073